Book a Meeting

β-Gal CircRNA-LNP

Cat. No.: TDLD-0825-LD59

β-Gal CircRNA-LNP

β-Gal CircRNA-LNP is a state-of-the-art circular RNA (CircRNA) lipid nanoparticle (LNP) system, specifically engineered for efficient in vitro and in vivo protein expression. This LNP encapsulates circRNA encoding β-Galactosidase (β-Gal), serving as an excellent tool for studying circRNA stability, expression kinetics, and as a reporter for assessing LNP delivery efficiency. Engineered with a proprietary lipid formulation for optimal mRNA encapsulation and delivery, it ensures high translation efficiency. We offer flexibility in lipid composition, including DLin-MC3-DMA, LP-01, ALC-0315, SM102, and targeted lipids for specific tissues (lung, liver, spleen, muscle), allowing for tailored delivery strategies. Our LNP ensures uniform particle size, high encapsulation efficiency, stability, and effective delivery. Applications of β-Gal CircRNA-LNP include monitoring circRNA-based protein expression and evaluating LNP transfection efficiency. Please note that this product is intended for research purposes only.

SPECIFIC INQUIRY
Payload:
Modification:
Lipid Formulation:
Dye:
Concentration:
Quantity:
Inquiry
For Research Use Only. Not for Diagnostic or Treatment Applications.
Payload Type CircRNA
Payload Beta-galactosidase CircRNA
Modification Unmodified
Module Type Unconjugation
Lipid Formulation DLin-MC3-DMA; LP-01; ALC-0315; SM102; Targeted Lipid (Please inquire)
Dye Unlabeled; DiR; DiD; DiO; DiI
Application Control; Targeted Delivery; Tracking and Imaging; Gene Therapy
Format Liquid
Concentration 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify)
Size 65-120 nm
PDI < 0.2
Zeta ± 20.0 mV
Encapsulate Efficiency >90%
Storage Store at 2-8°C
Related products
Online Inquiry
  • Email:
Social Media
ISO 9001 Certified - Creative Biolabs Quality Management System.
Copyright © 2025 Creative Biolabs. All Rights Reserved.
Close
Thanksgiving
Thanksgiving